Cat: IPD-X40369

Recombinant Saccharomyces cerevisiae RPN13 Protein ,His & SUMO

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    RPN13

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 别名

    Proteasome non-ATPase subunit 13

  • 种属

    Saccharomyces cerevisiae

  • 表达系统

    E. coli

  • 标签

    N- His-SUMO

  • 纯度

    Greater than 90% as determined by SDS-PAGE.

  • 蛋白编号

    O13563

  • 表达区间

    2-156aa

  • 分子量

    33.8 kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

RPN13, a pivotal component of the 26S proteasome, plays a critical role in the regulation of protein degradation, which is essential for maintaining cellular homeostasis and regulating various cellular processes, including cell cycle progression, apoptosis, and stress responses. Recent studies have highlighted the involvement of RPN13 in the recognition and processing of ubiquitinated substrates, thus ensuring that damaged or misfolded proteins are efficiently targeted for degradation. Its unique structure, featuring a ubiquitin-binding domain, allows RPN13 to interact directly with ubiquitin chains, facilitating the delivery of substrates to the proteasome. Furthermore, aberrations in RPN13 expression or function have been implicated in several diseases, including cancer and neurodegenerative disorders, making it an attractive target for therapeutic interventions. The recombinant expression of RPN13 not only aids in the elucidation of its biochemical properties and interaction mechanisms but also enables the development of potential inhibitors that could modulate its activity in pathological conditions. Investigating RPN13 as a recombinant protein presents a valuable opportunity to deepen our understanding of proteasomal regulation and to explore its therapeutic potential in enhancing proteostasis and targeting diseases associated with proteasome dysfunction.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US